Latest On Omeros Corporation (OMER):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-17 06:30 EST | News | Omeros: Q1 Earning Overview, Best Contrarian Biotech Play Of 2023 | N/A |  |
| 2023-05-10 05:46 EST | News | Omeros Corporation (OMER) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 16:40 EST | News | Omeros GAAP EPS of -$0.63 misses by $0.09 | N/A | |
| 2023-05-09 02:50 EST | News | Omeros Q1 2023 Earnings Preview | N/A | |
| 2023-04-25 20:18 EST | News | Omeros reports positive data for rare blood disorder candidate | N/A | |
| 2023-04-11 01:47 EST | News | Omeros awarded $6.69M grant from NIH for cocaine use disorder treatment | N/A | |
| 2023-03-27 18:48 EST | News | Omeros Q4: Strong Financials And IgAN Pipeline Readout In Q3 23 | N/A | |
| 2023-03-15 00:03 EST | News | Omeros stock climbs amid Q4 Omidria royalty revenue; eyes FDA refiling for narsoplimab | N/A | |
| 2023-03-14 08:12 EST | News | Omeros Corporation (OMER) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-13 17:09 EST | News | Omeros GAAP EPS of -$0.73 misses by $0.16 | N/A | |
| 2023-03-13 02:04 EST | News | Omeros Q4 2022 Earnings Preview | N/A | |
| 2023-02-08 10:56 EST | News | Omeros: $200M Added To The Company's Balance Sheet, Upgrading To Strong Buy | N/A | |
| 2023-02-06 20:54 EST | News | Omeros up 35% in premarket trading following $200M milestone payment | N/A | |
| 2023-02-04 12:40 EST | News | Omeros: Worst Has Been Priced In, We Like Its IgAN Pipeline, Initiating With A Buy | N/A | |
| 2022-12-27 10:19 EST | News | Omeros' Deafening Silence | N/A | |
| 2022-11-10 03:58 EST | News | Omeros GAAP EPS of -$0.28 beats by $0.28 | N/A | |
| 2022-11-10 03:58 EST | News | Omeros Corporation (OMER) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-09 10:03 EST | News | Omeros Q3 2022 Earnings Preview | N/A | |
| 2022-11-08 16:56 EST | News | Omeros appeal of FDA Complete Response Letter on narsoplimab denied; shares down 7% | N/A | |
| 2022-11-08 16:55 EST | News | Omeros downgraded at Bank of America after FDA snub for narsoplimab appeal | N/A | |
| 2022-11-01 13:32 EST | News | Omeros: FDA Appeal On Narsoplimab And Several 2023 Catalysts On Deck | N/A | |
| 2022-10-05 09:58 EST | News | Omeros: Taking It To The Max | N/A | |
| 2022-09-15 20:07 EST | News | Omeros falls 11% after reporting clinical data for COVID-19 therapy | N/A | |
| 2022-08-20 05:51 EST | News | Omeros: Off To Never-Never Land | N/A | |
| 2022-08-17 22:29 EST | News | Omeros receives response from FDA on formal dispute resolution request | N/A | |
| 2022-08-16 11:56 EST | News | Omeros: Managing An Investment After A Winning Trade | N/A | |
| 2022-08-10 03:57 EST | News | Omeros GAAP EPS of -$0.49 | N/A | |
| 2022-08-10 03:57 EST | News | Omeros Corporation (OMER) CEO Gregory Demopulos on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 06:07 EST | News | Omeros Q2 2022 Earnings Preview | N/A | |
| 2022-07-29 02:53 EST | News | Omeros granted FDA’s orphan drug designation for PNH candidate | N/A | |
| 2022-07-05 17:38 EST | News | After gaining 69% in single trading day, Omeros stock gives back some gains | N/A | |
| 2022-07-04 07:08 EST | News | Omeros: Follow The Bouncing Ball | N/A | |
| 2022-06-08 22:55 EST | News | Omeros slips to 52-week low as stock down 9% | N/A | |
| 2022-06-07 00:28 EST | News | Clover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletions | N/A | |
| 2022-06-02 12:43 EST | News | Omeros: On Death's Door | N/A | |
| 2022-05-12 03:01 EST | News | Omeros stock rises 7% after beating Q1 earnings estimate | N/A | |
| 2022-05-11 07:21 EST | News | Omeros GAAP EPS of -$0.53 beats by $0.08 | N/A | |
| 2022-05-11 07:21 EST | News | Omeros Corporation (OMER) CEO Greg Demopulos on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 11:19 EST | News | Omeros Q1 2022 Earnings Preview | N/A | |
| 2022-05-03 00:21 EST | News | Omeros: The Weight Of The Wait, A Conundrum | N/A | |
| 2022-03-02 04:45 EST | News | Omeros Non-GAAP EPS of -$0.37 misses by $0.31 | N/A | |
| 2022-03-02 04:44 EST | News | Omeros Corporation's (OMER) CEO Greg Demopulos On Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-01 10:49 EST | News | Omeros Q4 2021 Earnings Preview | N/A | |
| 2022-02-21 13:04 EST | News | Omeros: Despite Its Promise, The CRL Is A Huge Obstacle | N/A | |
| 2022-01-20 07:52 EST | News | Omeros responds to Complete Response Letter on narsoplimab for kidney damage | N/A | |
| 2022-01-19 00:54 EST | News | Omeros could trade as a pure-play biotech after divesting Omidria - Cantor | N/A | |
| 2021-12-06 20:03 EST | News | Omeros: A New Year Beckons | N/A | |
| 2021-12-02 22:53 EST | News | Omeros to sell OMIDRIA franchise to Rayner Surgical for more than $1B | N/A | |
| 2021-11-10 13:19 EST | News | Omeros EPS beats by $0.01, beats on revenue | N/A | |
| 2021-11-10 13:19 EST | News | Omeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call Transcript | N/A | |
About Omeros Corporation (OMER):
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. The company's clinical programs include Narsoplimab (OMS721/MASP-2) for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and COVID-19; and Phase II clinical trial to treat lupus nephritis and other renal diseases. Its clinical programs also consist of PPAR? (OMS405) to treat opioid and nicotine addiction; PDE7 (OMS527) for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs include G protein-coupled receptor (GPCR) platform, including GPR174, GPR151, GPR161, and other Class A orphan GPCRs for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.
General
- Name Omeros Corporation
- Symbol OMER
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 277
- Last Split Factor1:1
- Last Split Date2009-10-02
- Fiscal Year EndDecember
- IPO Date2009-10-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.omeros.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 15.4
- Enterprise Value Revenue 18.49
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.77
- Next Year EPS Estimate -$1.12
- Next Quarter EPS Estimate -$0.54
- Profit Margin -187%
- Operating Margin -150%
- Return on Assets -43%
- Revenue 73.81 million
- Earnings Per Share -$2.08
- Revenue Per Share $1.29
- Gross Profit 6.17 million
- Quarterly Earnings Growth -68.2%
View More
Highlights
- Market Capitalization 1.23 billion
- EBITDA -81135000
- PE Ratio -1.97
- PEG Ratio -0.17
- Analyst Target Price $27.33
- Book Value Per Share -$2.65
View More
Share Statistics
- Shares Outstanding 61.93 million
- Shares Float 55.03 million
- % Held by Insiders 441%
- % Held by Institutions 57.36%
- Shares Short 12.55 million
- Shares Short Prior Month 12.76 million
- Short Ratio 16
- Short % of Float 21%
- Short % of Shares Outstanding 20%
View More
Technicals
- Beta 1.42
- 52 Week High $23.14
- 52 Week Low $9.25
- 50 Day Moving Average 20.56
- 200 Day Moving Average 14.72
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Omeros Corporation (OMER) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Omeros Corporation (OMER) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $N/A | -$0.60 | -$0.67 | 10.39% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.34 | -$0.49 | 30.04% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.61 | -$0.59 | -4.1% |
| 2020-03-31 | 2020-05-11 | $23.54 million | -$0.53 | -$0.34 | -55.88% |
| 2019-12-31 | 2020-03-02 | $33.42 million | -$0.58 | -$0.40 | -45% |
| 2019-09-30 | 2019-11-12 | $29.86 million | -$0.33 | -$0.41 | 19.02% |
| 2019-06-30 | 2019-08-08 | $26.75 million | -$0.29 | -$0.44 | 34.09% |
| 2019-03-31 | 2019-05-09 | $21.78 million | -$0.50 | -$0.47 | -5.82% |
| 2018-12-31 | 2019-03-01 | $22.02 million | -$0.48 | -$0.73 | 33.89% |
| 2018-09-30 | 2018-11-08 | $4.61 million | -$0.81 | -$0.71 | -14.62% |
| 2018-06-30 | 2018-08-09 | $1.66 million | -$0.70 | -$0.62 | -12.45% |
| 2018-03-31 | 2018-05-10 | $1.59 million | -$0.62 | -$0.59 | -5.68% |
| 2017-12-31 | 2018-03-01 | $13.76 million | -$0.34 | -$0.18 | -91.55% |
| 2017-09-30 | 2017-11-09 | $21.66 million | -$0.16 | -$0.34 | 53.22% |
| 2017-06-30 | 2017-08-08 | $17.15 million | -$0.33 | -$0.37 | 10.81% |
| 2017-03-31 | 2017-05-10 | $12.26 million | -$0.34 | -$0.36 | 4.23% |
| 2016-12-31 | 2017-03-16 | $12.91 million | -$0.33 | -$0.56 | 41.96% |
| 2016-09-30 | 2016-11-09 | $11.29 million | -$0.34 | -$0.36 | 4.9% |
| 2016-06-30 | 2016-08-09 | $10 million | -$0.32 | -$0.49 | 34.16% |
| 2016-03-31 | 2016-05-10 | $7.42 million | -$0.54 | -$0.43 | -25.58% |
| 2015-12-31 | 2016-03-07 | $6.68 million | -$0.49 | -$0.59 | 17.87% |
| 2015-09-30 | 2015-11-09 | $3.26 million | -$0.53 | -$0.47 | -12.77% |
| 2015-06-30 | 2015-08-10 | $3.19 million | -$0.44 | -$0.56 | 21.43% |
| 2015-03-31 | 2015-05-11 | $388000 | -$0.51 | -$0.63 | 19.05% |
| 2014-12-31 | 2015-03-16 | $180000 | -$0.61 | -$0.62 | 1.61% |
| 2014-09-30 | 2014-11-10 | $214000 | -$0.54 | -$0.59 | 8.47% |
| 2014-06-30 | 2014-08-11 | $45000 | -$0.53 | -$0.56 | 5.36% |
| 2014-03-31 | 2014-05-12 | $100000 | -$0.54 | -$0.45 | -20% |
| 2013-12-31 | 2014-03-13 | $169000 | -$0.47 | -$0.38 | -23.68% |
| 2013-09-30 | 2013-11-07 | $196000 | -$0.46 | -$0.44 | -4.55% |
| 2013-06-30 | 2013-08-09 | $140000 | -$0.48 | -$0.38 | -26.32% |
| 2013-03-31 | 2013-05-10 | $1.1 million | -$0.40 | -$0.39 | -2.56% |
| 2012-12-31 | 2013-03-18 | $1.58 million | -$0.45 | -$0.34 | -32.35% |
| 2012-09-30 | 2012-11-09 | $1.42 million | -$0.36 | -$0.34 | -5.88% |
| 2012-06-30 | 2012-08-07 | $1.53 million | -$0.38 | -$0.36 | -5.56% |
| 2012-03-31 | 2012-05-10 | $1.5 million | -$0.35 | -$0.36 | 2.78% |
| 2011-12-31 | 2012-03-15 | $1.14 million | -$0.46 | -$0.35 | -31.43% |
| 2011-09-30 | 2011-11-08 | $987000 | -$0.29 | -$0.38 | 23.68% |
| 2011-06-30 | 2011-08-09 | $1.16 million | -$0.24 | -$0.38 | 36.84% |
| 2011-03-31 | 2011-05-10 | $1.24 million | -$0.30 | -$0.39 | 23.08% |
| 2010-12-31 | 2011-03-15 | $976000 | -$0.32 | -$0.49 | 34.69% |
| 2010-09-30 | 2010-11-04 | $254000 | -$0.35 | -$0.39 | 10.26% |
| 2010-06-30 | 2010-08-10 | $497000 | -$0.36 | -$0.33 | -9.09% |
| 2010-03-31 | 2010-05-12 | $378000 | -$0.31 | -$0.30 | -3.33% |
| 2009-12-31 | 2010-03-31 | $434000 | -$0.28 | -$0.27 | -3.7% |
| 2009-09-30 | 2009-11-19 | $442000 | -$0.33 | -$0.37 | 10.81% |
Omeros Corporation (OMER) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Omeros Corporation (OMER) Chart:
Omeros Corporation (OMER) News:
Below you will find a list of latest news for Omeros Corporation (OMER) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Omeros Corporation (OMER) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 1 | 2.55 | CALL | 0 | 119 | 618.28 | TRUE | 0 | 0 |
| 2025-01-17 | 2 | 1.9 | CALL | 0 | 117 | 99.37 | TRUE | 0 | 0 |
| 2025-01-17 | 3 | 1 | CALL | 0 | 1004 | 90.65 | TRUE | 0 | 0 |
| 2025-01-17 | 4 | 0.71 | CALL | 0 | 945 | 91.25 | FALSE | 0 | 0 |
| 2025-01-17 | 5 | 0.5 | CALL | 0 | 1589 | 86.85 | FALSE | 0 | 0 |
| 2025-01-17 | 6 | 0.31 | CALL | 0 | 1277 | 96.24 | FALSE | 0 | 0 |
| 2025-01-17 | 7 | 0.2 | CALL | 0 | 1395 | 101.4 | FALSE | 0 | 0 |
| 2025-01-17 | 8 | 0.65 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 9 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 10 | 0.1 | CALL | 0 | 2747 | 106.98 | FALSE | 0 | 0 |
| 2025-01-17 | 12 | 0.1 | CALL | 0 | 995 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 15 | 0.3 | CALL | 0 | 771 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 1 | 0.15 | PUT | 0 | 68 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 2 | 0.05 | PUT | 0 | 1042 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 3 | 0.79 | PUT | 0 | 1793 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 4 | 0.76 | PUT | 0 | 391 | 96.7 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 1.5 | PUT | 0 | 1143 | 96.45 | TRUE | 0 | 0 |
| 2025-01-17 | 6 | 2.4 | PUT | 10 | 40 | 97.14 | TRUE | 2.4 | 0 |
| 2025-01-17 | 7 | 3.2 | PUT | 0 | 68 | 107.21 | TRUE | 0 | 0 |
| 2025-01-17 | 8 | 0 | PUT | 0 | 0 | 102.06 | TRUE | 0 | 0 |
| 2025-01-17 | 9 | 0 | PUT | 0 | 0 | 98.55 | TRUE | 0 | 0 |
| 2025-01-17 | 10 | 7 | PUT | 0 | 0 | 135.1 | TRUE | 0 | 0 |
| 2025-01-17 | 12 | 9.2 | PUT | 0 | 0 | 124.78 | TRUE | 0 | 0 |
| 2025-01-17 | 15 | 0 | PUT | 0 | 0 | 144.89 | TRUE | 0 | 0 |
| 2025-02-21 | 1 | 0 | CALL | 0 | 0 | 154.04 | TRUE | 0 | 0 |
| 2025-02-21 | 2 | 0 | CALL | 0 | 0 | 98.95 | TRUE | 0 | 0 |
| 2025-02-21 | 3 | 1.49 | CALL | 0 | 203 | 108.69 | TRUE | 0 | 0 |
| 2025-02-21 | 4 | 0.92 | CALL | 0 | 225 | 92 | FALSE | 0 | 0 |
| 2025-02-21 | 5 | 0.65 | CALL | 0 | 130 | 93.73 | FALSE | 0 | 0 |
| 2025-02-21 | 6 | 1.25 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 7 | 0.3 | CALL | 0 | 62 | 94.64 | FALSE | 0 | 0 |
| 2025-02-21 | 8 | 0.7 | CALL | 0 | 60 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 9 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-02-21 | 3 | 0.5 | PUT | 1 | 25 | 104.78 | FALSE | 0.05 | 0.11 |
| 2025-02-21 | 4 | 0.95 | PUT | 0 | 33 | 93.07 | TRUE | 0 | 0 |
| 2025-02-21 | 5 | 1.5 | PUT | 0 | 10 | 93.21 | TRUE | 0 | 0 |
| 2025-02-21 | 6 | 0 | PUT | 0 | 0 | 92.34 | TRUE | 0 | 0 |
| 2025-02-21 | 7 | 3.18 | PUT | 0 | 2 | 95.38 | TRUE | 0 | 0 |
| 2025-02-21 | 8 | 0 | PUT | 0 | 0 | 79.24 | TRUE | 0 | 0 |
| 2025-02-21 | 9 | 0 | PUT | 0 | 0 | 89.12 | TRUE | 0 | 0 |
| 2025-02-21 | 10 | 0 | PUT | 0 | 0 | 97.84 | TRUE | 0 | 0 |
| 2025-05-16 | 1 | 0 | CALL | 0 | 0 | 160.61 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 0 | CALL | 0 | 0 | 95.93 | TRUE | 0 | 0 |
| 2025-05-16 | 3 | 1.68 | CALL | 0 | 10 | 145.79 | TRUE | 0 | 0 |
| 2025-05-16 | 4 | 1.2 | CALL | 0 | 10 | 93.68 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0 | CALL | 0 | 0 | 92.31 | FALSE | 0 | 0 |
| 2025-05-16 | 6 | 0.67 | CALL | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 7 | 0.4 | CALL | 0 | 65 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 8 | 0.3 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 2 | 0.3 | PUT | 0 | 2500 | 108.73 | FALSE | 0 | 0 |
| 2025-05-16 | 3 | 0 | PUT | 0 | 0 | 103.24 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0 | PUT | 0 | 0 | 101.58 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 0 | PUT | 0 | 0 | 99.03 | TRUE | 0 | 0 |
| 2025-05-16 | 6 | 0 | PUT | 0 | 0 | 102.38 | TRUE | 0 | 0 |
| 2025-05-16 | 7 | 0 | PUT | 0 | 0 | 107.63 | TRUE | 0 | 0 |
| 2025-05-16 | 8 | 0 | PUT | 0 | 0 | 100.16 | TRUE | 0 | 0 |
Latest OMER Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $2.015 |
| Jun 13, 2022 7:59 PM EST | 100 | $2.015 |
| Jun 13, 2022 7:59 PM EST | 388 | $2.015 |
| Jun 13, 2022 7:59 PM EST | 112 | $2.015 |
| Jun 13, 2022 7:59 PM EST | 42 | $2.015 |
Omeros Corporation (OMER) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm |
| 2019-12-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1285819/000000000019016861/0000000000-19-016861-index.htm |
| 2020-01-31 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1285819/000000000020000924/0000000000-20-000924-index.htm |
| 2018-01-29 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000021545718003528/0000215457-18-003528-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000021545719004932/0000215457-19-004932-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000083423720005992/0000834237-20-005992-index.htm |
| 2017-12-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm |
| 2018-01-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm |
| 2018-01-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm |
| 2018-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318009872/0000899243-18-009872-index.htm |
| 2018-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318009873/0000899243-18-009873-index.htm |
| 2018-04-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318010008/0000899243-18-010008-index.htm |
| 2018-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318017006/0000899243-18-017006-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318017007/0000899243-18-017007-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318017008/0000899243-18-017008-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318017010/0000899243-18-017010-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318017011/0000899243-18-017011-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318017013/0000899243-18-017013-index.htm |
| 2018-07-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm |
| 2018-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm |
| 2018-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2019-02-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319003362/0000899243-19-003362-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319003363/0000899243-19-003363-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319003364/0000899243-19-003364-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319003365/0000899243-19-003365-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319003367/0000899243-19-003367-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016489/0000899243-19-016489-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016490/0000899243-19-016490-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016492/0000899243-19-016492-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016495/0000899243-19-016495-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016497/0000899243-19-016497-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016501/0000899243-19-016501-index.htm |
| 2019-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016504/0000899243-19-016504-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016506/0000899243-19-016506-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm |
| 2020-02-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924320004399/0000899243-20-004399-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000089924320004400/0000899243-20-004400-index.htm |
| 2017-11-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000092963817000842/0000929638-17-000842-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000092963818000300/0000929638-18-000300-index.htm |
| 2020-05-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000092963820000579/0000929638-20-000579-index.htm |
| 2018-02-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000104188518000012/0001041885-18-000012-index.htm |
| 2019-01-30 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000104188519000016/0001041885-19-000016-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000104188520000011/0001041885-20-000011-index.htm |
| 2019-12-04 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1285819/000104746919006632/0001047469-19-006632-index.htm |
| 2019-12-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1285819/000104746919006643/0001047469-19-006643-index.htm |
| 2019-12-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1285819/000104746919006722/0001047469-19-006722-index.htm |
| 2020-08-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1285819/000104746920004475/0001047469-20-004475-index.htm |
| 2020-08-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1285819/000104746920004476/0001047469-20-004476-index.htm |
| 2020-08-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1285819/000104746920004572/0001047469-20-004572-index.htm |
| 2020-08-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1285819/000104746920004574/0001047469-20-004574-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000108514620000787/0001085146-20-000787-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000110465919070697/0001104659-19-070697-index.htm |
| 2020-01-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1285819/000110465920002951/0001104659-20-002951-index.htm |
| 2020-01-13 | AW | Amendment Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1285819/000110465920003470/0001104659-20-003470-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000110465920021736/0001104659-20-021736-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000110465920021842/0001104659-20-021842-index.htm |
| 2020-08-10 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1285819/000110465920092744/0001104659-20-092744-index.htm |
| 2020-08-10 | 305B2 | Filing [Trust Indenture Act] | https://www.sec.gov/Archives/edgar/data/1285819/000110465920092747/0001104659-20-092747-index.htm |
| 2020-08-12 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1285819/000110465920093476/0001104659-20-093476-index.htm |
| 2020-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000110465920095326/0001104659-20-095326-index.htm |
| 2019-03-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000114420419012997/0001144204-19-012997-index.htm |
| 2019-05-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000114420419025259/0001144204-19-025259-index.htm |
| 2017-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312517265505/0001193125-17-265505-index.htm |
| 2017-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312517304636/0001193125-17-304636-index.htm |
| 2017-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312517311379/0001193125-17-311379-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000119312518045759/0001193125-18-045759-index.htm |
| 2018-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518096839/0001193125-18-096839-index.htm |
| 2018-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518116023/0001193125-18-116023-index.htm |
| 2018-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518169610/0001193125-18-169610-index.htm |
| 2018-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518172720/0001193125-18-172720-index.htm |
| 2018-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518195704/0001193125-18-195704-index.htm |
| 2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518294184/0001193125-18-294184-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518322542/0001193125-18-322542-index.htm |
| 2018-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312518327708/0001193125-18-327708-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312519009075/0001193125-19-009075-index.htm |
| 2019-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312519036058/0001193125-19-036058-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1285819/000119312519038252/0001193125-19-038252-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000119312519059222/0001193125-19-059222-index.htm |
| 2019-03-01 | POSASR | Post-effective Amendment to an automatic shelf registration statement | https://www.sec.gov/Archives/edgar/data/1285819/000119312519059276/0001193125-19-059276-index.htm |
| 2019-03-01 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1285819/000119312519059320/0001193125-19-059320-index.htm |
| 2019-06-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1285819/000119312519170318/0001193125-19-170318-index.htm |
| 2018-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1285819/000128581918000003/0001285819-18-000003-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000128581918000006/0001285819-18-000006-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000128581918000011/0001285819-18-000011-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000128581918000014/0001285819-18-000014-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920000610/0001415889-20-000610-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920000611/0001415889-20-000611-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920000612/0001415889-20-000612-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001531/0001415889-20-001531-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001532/0001415889-20-001532-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001533/0001415889-20-001533-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001534/0001415889-20-001534-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001535/0001415889-20-001535-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001536/0001415889-20-001536-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001537/0001415889-20-001537-index.htm |
| 2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1285819/000141588920002497/0001415889-20-002497-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837019006625/0001558370-19-006625-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837019007697/0001558370-19-007697-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837019007698/0001558370-19-007698-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000155837019007702/0001558370-19-007702-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837019010800/0001558370-19-010800-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000155837019010806/0001558370-19-010806-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837020000682/0001558370-20-000682-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837020001887/0001558370-20-001887-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1285819/000155837020001891/0001558370-20-001891-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1285819/000155837020004646/0001558370-20-004646-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1285819/000155837020004658/0001558370-20-004658-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837020006245/0001558370-20-006245-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000155837020006254/0001558370-20-006254-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000155837020010177/0001558370-20-010177-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000155837020010182/0001558370-20-010182-index.htm |
| 2017-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000156459017023228/0001564590-17-023228-index.htm |
| 2018-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000156459018004112/0001564590-18-004112-index.htm |
| 2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1285819/000156459018009842/0001564590-18-009842-index.htm |
| 2018-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000156459018012972/0001564590-18-012972-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000156459018021051/0001564590-18-021051-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1285819/000156459019013704/0001564590-19-013704-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000156459019017957/0001564590-19-017957-index.htm |
| 2019-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1285819/000156459019022265/0001564590-19-022265-index.htm |
| 2017-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000162828017011326/0001628280-17-011326-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1285819/000162828019002324/0001628280-19-002324-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1285819/000162828019006430/0001628280-19-006430-index.htm |
| 2018-10-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1285819/999999999718008375/9999999997-18-008375-index.htm |
| 2019-04-04 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1285819/999999999719002349/9999999997-19-002349-index.htm |
| 2019-09-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1285819/999999999719006776/9999999997-19-006776-index.htm |
| 2020-08-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1285819/999999999720004327/9999999997-20-004327-index.htm |
Omeros Corporation (OMER) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omeros Corporation (OMER). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 441%Institutional Ownership: 5736%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-05-15 | MICHAEL A JACOBSEN | VP Finance and CAO | Buy | 5,000.00 | 9.37 | 46,850.00 | 13,500.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm |
| 2018-01-03 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 62,528.00 | 21.45 | 1,341,225.60 | 176,641.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm |
| 2018-01-03 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 3,000.00 | 6.05 | 18,150.00 | 179,641.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm |
| 2018-01-03 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 5,004.00 | 6.05 | 30,274.20 | 184,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm |
| 2018-07-12 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 4,277.00 | 21.48 | 91,886.21 | 184,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm |
| 2018-07-26 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 35,000.00 | 21.53 | 753,686.50 | 184,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm |
| 2019-12-14 | Peter A MD Demopulos | Director | Buy | 3,334.00 | 7.56 | 25,205.04 | 188,516.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm |
| 2018-07-12 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 4,277.00 | 4.10 | 17,535.70 | 188,922.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm |
| 2018-07-26 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 8,000.00 | 6.05 | 48,400.00 | 192,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm |
| 2018-07-27 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 5,723.00 | 21.73 | 124,356.78 | 192,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm |
| 2018-08-30 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 35,000.00 | 24.45 | 855,750.00 | 192,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2018-08-31 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 5,337.00 | 25.93 | 138,376.13 | 192,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2018-05-14 | MICHAEL A JACOBSEN | VP Finance and CAO | Buy | 10,980.00 | 9.37 | 102,882.60 | 19,480.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm |
| 2018-08-31 | Marcia S. Kelbon | VP Patent and General Counsel | Sell | 2,192.00 | 25.31 | 55,469.44 | 197,982.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2018-07-27 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 5,723.00 | 4.10 | 23,464.30 | 198,368.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm |
| 2017-12-28 | Gregory A MD Demopulos | Chairman, CEO & President | Buy | 102,040.00 | 2.45 | 249,998.00 | 1,987,025.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm |
| 2018-08-31 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 7,529.00 | 4.10 | 30,868.90 | 200,174.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2018-08-31 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 8,000.00 | 6.05 | 48,400.00 | 200,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2017-12-28 | Gregory A MD Demopulos | Chairman, CEO & President | Buy | 39,961.00 | 4.10 | 163,840.10 | 2,026,986.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm |
| 2019-06-07 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 10,000.00 | 6.05 | 60,500.00 | 210,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm |
| 2018-05-15 | MICHAEL A JACOBSEN | VP Finance and CAO | Buy | 12,812.00 | 9.37 | 120,048.44 | 21,312.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm |
| 2018-07-26 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 35,000.00 | 4.10 | 143,500.00 | 219,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm |
| 2018-08-30 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 35,000.00 | 4.10 | 143,500.00 | 227,645.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm |
| 2018-01-03 | Marcia S. Kelbon | VP Patent and General Counsel | Buy | 62,528.00 | 9.37 | 585,887.36 | 239,169.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm |
| 2019-10-14 | Thomas J. Cable | Director | Sell | 5,000.00 | 15.12 | 75,590.00 | 35,067.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm |
| 2019-12-03 | Thomas J. Cable | Director | Sell | 10,000.00 | 14.41 | 144,148.00 | 35,067.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm |
| 2020-05-13 | Thomas J. Cable | Director | Sell | 5,000.00 | 14.40 | 71,998.50 | 35,067.00 | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm |
| 2020-05-13 | Thomas J. Cable | Director | Buy | 5,000.00 | 5.92 | 29,600.00 | 40,067.00 | https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm |
| 2019-12-03 | Thomas J. Cable | Director | Buy | 10,000.00 | 7.56 | 75,600.00 | 45,067.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm |
| 2019-12-14 | Leroy E. MD PhD Hood | Director | Buy | 10,000.00 | 7.56 | 75,600.00 | 64,390.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm |
| 2020-03-13 | Leroy E. MD PhD Hood | Director | Buy | 5,000.00 | 5.92 | 29,600.00 | 69,390.00 | https://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm |
| 2018-01-03 | MICHAEL A JACOBSEN | VP Finance and CAO | Sell | 1,020.00 | 22.45 | 22,899.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm |
| 2018-01-04 | MICHAEL A JACOBSEN | VP Finance and CAO | Buy | 1,000.00 | 9.37 | 9,370.00 | 8,500.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm |
| 2018-05-14 | MICHAEL A JACOBSEN | VP Finance and CAO | Sell | 10,980.00 | 22.45 | 246,501.00 | 8,500.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm |
| 2018-05-15 | MICHAEL A JACOBSEN | VP Finance and CAO | Sell | 12,812.00 | 24.95 | 319,659.40 | 8,500.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm |
| 2018-01-03 | MICHAEL A JACOBSEN | VP Finance and CAO | Buy | 1,020.00 | 9.37 | 9,557.40 | 8,520.00 | https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm |